149 related articles for article (PubMed ID: 37810973)
61. Chemotherapy Combined With Recombinant Human Endostatin (Endostar) Significantly Improves the Progression-Free Survival of Stage IV Soft Tissue Sarcomas.
Liao Z; Zhang C; Yang T; Liu H; Yang S; Li T; Xing R; Teng S; Yang Y; Zhao J; Zhao G; Bai X; Zhu L; Yang J
Front Oncol; 2021; 11():778774. PubMed ID: 35047396
[TBL] [Abstract][Full Text] [Related]
62. Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study.
Smyth EN; Bapat B; Ball DE; André T; Kaye JA
Clin Ther; 2015 Jun; 37(6):1301-16. PubMed ID: 25907619
[TBL] [Abstract][Full Text] [Related]
63. Efficacy and safety of sintilimab-based regimens against advanced gastric and gastroesophageal junction adenocarcinoma.
Wang Y; Zhao J; Yu H; Wang J; Zhang N; Cao B
J Cancer Res Ther; 2021 Nov; 17(5):1234-1240. PubMed ID: 34850772
[TBL] [Abstract][Full Text] [Related]
64. Comparison of gemcitabine plus oxaliplatin versus gemcitabine plus nab-paclitaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma: A single-center retrospective analysis.
Schlick K; Gantschnigg A; Seymer A; Huemer F; Greil R; Weiss L
Cancer Med; 2023 Aug; 12(16):16997-17004. PubMed ID: 37537780
[TBL] [Abstract][Full Text] [Related]
65. Sequence Therapy with FOLFIRINOX and Gemcitabine/Nab-Paclitaxel for Patients with Advanced Pancreatic Cancer: A Monocentre Retrospective Cohort Study.
Queck A; Elango S; Koch C; Walter D; Schmidt J; Trebicka J; Trojan J; Pession U; Finkelmeier F; Waidmann O
Oncol Res Treat; 2022; 45(3):79-87. PubMed ID: 34875671
[TBL] [Abstract][Full Text] [Related]
66. Clinical outcomes of FOLFIRINOX and gemcitabine-nab paclitaxel for metastatic pancreatic cancer in the real world setting.
Franco F; Camara JC; Martín-Valadés JI; López-Alfonso A; Marrupe D; Gutiérrez-Abad D; Martínez-Amores B; León A; Juez I; Pérez M; Royuela A; Ruiz-Casado A
Clin Transl Oncol; 2021 Apr; 23(4):812-819. PubMed ID: 32857340
[TBL] [Abstract][Full Text] [Related]
67. Phase II study of biweekly cetuximab plus mFOLFOX6 or mFOLFIRI as second-line treatment for metastatic colorectal cancer and exploratory analysis of associations between DNA methylation status and the efficacy of the anti-EGFR antibody: T-CORE1201.
Takahashi S; Ouchi K; Sakamoto Y; Mori T; Shimodaira H; Takahashi M; Ohori H; Kudo C; Takahashi Y; Imai H; Akiyama S; Takahashi M; Suto T; Murakawa Y; Oishi T; Isobe H; Okada Y; Kawai S; Yoshioka T; Sato T; Shindo Y; Sugiyama S; Komine K; Chiba N; Okita A; Yamaguchi T; Ishioka C
J Gastrointest Oncol; 2023 Apr; 14(2):676-691. PubMed ID: 37201044
[TBL] [Abstract][Full Text] [Related]
68. The efficacy and toxicity of chemotherapy in the elderly with advanced pancreatic cancer.
Li X; Huang DB; Zhang Q; Guo CX; Fu QH; Zhang XC; Tang TY; Su W; Chen YW; Chen W; Ma T; Gao SL; Que RS; Bai XL; Liang TB
Pancreatology; 2020 Jan; 20(1):95-100. PubMed ID: 31786057
[TBL] [Abstract][Full Text] [Related]
69. Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter study.
Pointet AL; Tougeron D; Pernot S; Pozet A; Béchade D; Trouilloud I; Lourenco N; Hautefeuille V; Locher C; Williet N; Desrame J; Artru P; Soularue E; Le Roy B; Taieb J
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):295-301. PubMed ID: 31607641
[TBL] [Abstract][Full Text] [Related]
70. Comparison of bevacizumab plus chemotherapy with chemotherapy alone in advanced non-small-lung cancer patients.
Tang N; Wang Z
Onco Targets Ther; 2016; 9():4671-9. PubMed ID: 27536131
[TBL] [Abstract][Full Text] [Related]
71. [Efficacy of salvage chemotherapy in the advanced non-small cell lung cancer patients who failed the treatment of chemotherapy and EGFR-TKI].
Fan Y; Huang ZY; Yu HF; Luo LH
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):859-63. PubMed ID: 21223694
[TBL] [Abstract][Full Text] [Related]
72. Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM).
Ciardiello D; Chiarazzo C; Famiglietti V; Damato A; Pinto C; Zampino MG; Castellano G; Gervaso L; Zaniboni A; Oneda E; Rapisardi S; Bordonaro R; Zichi C; De Vita F; Di Maio M; Parisi A; Giampieri R; Berardi R; Lavacchi D; Antonuzzo L; Tamburini E; Maiorano BA; Parrella P; Latiano TP; Normanno N; De Stefano A; Avallone A; Martini G; Napolitano S; Troiani T; Martinelli E; Ciardiello F; De Vita F; Maiello E
ESMO Open; 2022 Oct; 7(5):100567. PubMed ID: 35994791
[TBL] [Abstract][Full Text] [Related]
73. The Effect of Long-Term Traditional Chinese Medicine Treatment on Survival Time of Colorectal Cancer Based on propensity Score Matching: A Retrospective Cohort Study.
Wang Y; Liu P; Fang Y; Tian J; Li S; Xu J; Zhao F; Yin X; Zhang Q; Li Y
Evid Based Complement Alternat Med; 2020; 2020():7023420. PubMed ID: 32089727
[TBL] [Abstract][Full Text] [Related]
74. [Correlation between the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors and EGFR mutations in advanced squamous cell lung cancer].
Duan JC; An TT; Wu MN; Yang L; Bai H; Wang ZJ; Wang YY; Zhuo ML; Zhao J; Wang SH; Wang J
Zhonghua Jie He He Hu Xi Za Zhi; 2012 May; 35(5):323-8. PubMed ID: 22883988
[TBL] [Abstract][Full Text] [Related]
75. Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer.
Sawada M; Kasuga A; Mie T; Furukawa T; Taniguchi T; Fukuda K; Yamada Y; Takeda T; Kanata R; Matsuyama M; Sasaki T; Ozaka M; Sasahira N
BMC Cancer; 2020 May; 20(1):449. PubMed ID: 32434547
[TBL] [Abstract][Full Text] [Related]
76. Microsatellite stable metastatic colorectal cancer without liver metastasis may be preferred population for regorafenib or fruquintinib plus sintilimab as third-line or above therapy:A real-world study.
Nie C; Lv H; Chen B; Xu W; Wang J; Liu Y; Wang S; Zhao J; He Y; Chen X
Front Oncol; 2022; 12():917353. PubMed ID: 36226061
[TBL] [Abstract][Full Text] [Related]
77. Efficacy of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer: A Real-life Experience and Outcome from a Tertiary Care Centre.
Yasmeen S; Arshad F; Shaukat S; Badar F; Kazmi SAS; Ahmad U
J Cancer Allied Spec; 2021; 7(2):e409. PubMed ID: 37197218
[TBL] [Abstract][Full Text] [Related]
78. [Multicenter real world study on the efficacy and safety of eribulin for the treatment of advanced breast cancer].
Sang D; Song LH; Di LJ; Wang YL; Liu CG; Guo ZQ; Liu QY; Wang H; Li SY; Yuan P
Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):364-369. PubMed ID: 35448926
[No Abstract] [Full Text] [Related]
79. Efficacy and Safety of Anlotinib in the Treatment of Small Cell Lung Cancer: A Real-World Observation Study.
Yuan J; Cheng F; Xiao G; Wang X; Fan H
Front Oncol; 2022; 12():917089. PubMed ID: 35795060
[TBL] [Abstract][Full Text] [Related]
80. Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian "Real-World" SAX Study.
D'Aniello C; Vitale MG; Farnesi A; Calvetti L; Laterza MM; Cavaliere C; Della Pepa C; Conteduca V; Crispo A; De Vita F; Grillone F; Ricevuto E; De Tursi M; De Vivo R; Di Napoli M; Cecere SC; Iovane G; Amore A; Piscitelli R; Quarto G; Pisconti S; Ciliberto G; Maiolino P; Muto P; Perdonà S; Berretta M; Naglieri E; Galli L; Cartenì G; De Giorgi U; Pignata S; Facchini G; Rossetti S
Front Pharmacol; 2016; 7():331. PubMed ID: 27733829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
